IQVIA BIOTECH LTD.
Operating as a subsidiary of the NYSE-listed American healthcare data and clinical research group IQVIA Holdings Inc., the company provides clinical trial and commercialisation services specifically tailored for smaller biotechnology firms.
Get an alert when IQVIA BIOTECH LTD. files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£34m
Latest balance sheet
Net assets
£295m
+8.1% vs 2024
Employees
117
-19.3% lowest in 3 filed years
Profit before tax
£22m
-59.1% lowest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £108,865,000 | £76,760,000 | £78,977,000 | +2.9% | |
| Operating profit | £43,183,000 | £23,783,000 | £20,993,000 | -11.7% | |
| Profit before tax | £45,487,000 | £53,684,000 | £21,938,000 | -59.1% | |
| Net profit | £36,983,000 | £53,530,000 | £22,066,000 | -58.8% | |
| Cash | — | £0 | £33,775,000 | — | |
| Total assets less current liabilities | £329,242,000 | £273,644,000 | £295,817,000 | +8.1% | |
| Net assets | £329,149,000 | £272,707,000 | £294,759,000 | +8.1% | |
| Equity | £329,149,000 | £272,707,000 | £294,759,000 | +8.1% | |
| Average employees | 172 | 145 | 117 | -19.3% | |
| Wages | £10,650,000 | £8,263,000 | £6,831,000 | -17.3% | |
| Directors' remuneration | £236,000 | £298,000 | £138,000 | -53.7% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 39.7% | 31.0% | 26.6% | |
| Net margin | 34.0% | 69.7% | 27.9% | |
| Return on capital employed | 13.1% | 8.7% | 7.1% | |
| Current ratio | 3.83x | 2.61x | 5.21x | |
| Interest cover | — | 87.76x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- IQVIA BIOTECH LTD. 2019-02-04 → present
- NOVELLA CLINICAL LTD 2009-07-02 → 2019-02-04
- MATRIX CONTRACT RESEARCH LTD. 1997-01-06 → 2009-07-02
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the above, the company's directors have a reasonable expectation that the company will be able to continue in operational existence for the foreseeable future and meet its liabilities as they fall due for a period of at least twelve months from the date the directors sign the financial statements of the company. Thus, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JTC (UK) LIMITED | Corporate Secretary | 2023-06-20 | — | — |
| MORTON-MORYS, Andrea | Director | 2026-01-21 | Oct 1969 | British |
| RANDALL, Kerry Louise | Director | 2025-07-04 | Jul 1980 | British |
| TURLAND, Kevin John | Director | 2014-02-28 | Mar 1969 | British |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| NEWMAN, Lisa Jane | Secretary | 1997-01-06 | 2008-06-10 |
| STAUB III, Walter Richard | Secretary | 2008-06-10 | 2013-10-16 |
| WILSON, Michael Norman | Secretary | 2013-10-16 | 2014-02-28 |
| HALCO SECRETARIES LIMITED | Corporate Secretary | 2018-09-04 | 2023-06-20 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 1997-01-06 | 1997-01-06 |
| ANGUS, Steven David | Director | 2021-03-26 | 2025-07-01 |
| HOOTON, Megan Stella | Director | 2025-07-04 | 2026-03-31 |
| LAMBERT, Charles Roger | Director | 2011-06-08 | 2013-10-16 |
| LATTIMORE, Barry Keith | Director | 2018-12-18 | 2020-05-29 |
| MACDONALD, Alasdair | Director | 2013-10-16 | 2018-12-31 |
| SMYTH, Christopher David | Director | 2021-03-26 | 2022-11-30 |
| STAUB 111, Walter Richard | Director | 2008-05-20 | 2013-10-16 |
| TRIM, Nigel Rupert | Director | 1997-01-06 | 2011-11-28 |
| WILSON, Michael Norman | Director | 2013-10-16 | 2014-02-28 |
| INSTANT COMPANIES LIMITED | Corporate Nominee Director | 1997-01-06 | 1997-01-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Iqvia Ltd. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-10-30 | Active |
| Iqvia Rds Uk Holdings Ltd. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2017-11-03 | Ceased 2020-10-30 |
Filing timeline
Last 20 of 135 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-07-29 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-11 | AA | accounts | Accounts with accounts type full | |
| 2026-06-22 | AP01 | officers | Appoint person director company with name date | |
| 2026-06-17 | CH01 | officers | Change person director company with change date | |
| 2026-04-13 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-22 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-07 | AA | accounts | Accounts with accounts type full | |
| 2025-01-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-12-09 | SH01 | capital | Capital allotment shares | |
| 2024-07-29 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2024-07-29 | SH20 | capital | Legacy | |
| 2024-07-29 | CAP-SS | insolvency | Legacy | |
| 2024-07-29 | RESOLUTIONS | resolution | Resolution | |
| 2024-07-10 | AA | accounts | Accounts with accounts type full | |
| 2024-01-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-06 | CH01 | officers | Change person director company with change date | |
| 2023-09-25 | AD02 | address | Change sail address company with old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 1
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.